Denver Investment Advisors’s Core Laboratories CLB Stock Holding History

Denver Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$7.09M	Sell	65,561 -154	-0.2%	-$17K	0.37%	101
2017 Q4	$7.2M	Sell	65,715 -1,848	-3%	-$184K	0.36%	106
2017 Q3	$6.67M	Sell	67,563 -498	-0.7%	-$48.3K	0.33%	109
2017 Q2	$6.89M	Buy	68,061 +2,920	+4%	+$315K	0.3%	112
2017 Q1	$7.53M	Buy	65,141 +2,024	+3%	+$235K	0.34%	110
2016 Q4	$7.58M	Sell	63,117 -9,269	-13%	-$1.03M	0.32%	110
2016 Q3	$8.13M	Buy	72,386 +1,163	+2%	+$134K	0.36%	106
2016 Q2	$8.82M	Buy	71,223 +567	+0.8%	+$68.4K	0.4%	107
2016 Q1	$7.94M	Buy	70,656 +1,923	+3%	+$200K	0.35%	110
2015 Q4	$7.47M	Buy	68,733 +29	+0%	+$3.32K	0.34%	109
2015 Q3	$6.86M	Buy	68,704 +1,615	+2%	+$176K	0.3%	112
2015 Q2	$7.65M	Buy	+67,089	New	+$8.14M	0.28%	107
2014 Q2	–	Sell	-46,128	Closed	-$9.15M	–	620
2014 Q1	$9.15M	Sell	46,128 -1,298	-3%	-$245K	0.27%	122
2013 Q4	$9.06K	Sell	47,426 -13,204	-22%	-$2.46M	0.26%	131
2013 Q3	$10.3M	Buy	60,630 +35,133	+138%	+$5.45M	0.22%	136
2013 Q2	$3.87M	Buy	+25,497	New	+$3.61M	0.09%	240

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Denver Investment Advisors's CLB Position: Q1 2018 in Review

Denver Investment Advisors reduced its Core Laboratories (CLB) stake by 0.23% in Q1 2018, selling an estimated $17K and leaving 65,561 shares worth $7.09M. The position accounts for 0.37% of the portfolio, ranked #101.

Denver Investment Advisors first reported a position in CLB in Q2 2013 and has held it in 16 quarters since. The position peaked at $10.3M in Q3 2013. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

Denver Investment Advisors held 65,561 shares of Core Laboratories worth $7.09M as of Q1 2018.
Denver Investment Advisors sold 154 Core Laboratories shares in Q1 2018, an estimated $17K.
Core Laboratories made up 0.37% of Denver Investment Advisors's portfolio in Q1 2018, its #101 holding.
Denver Investment Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 16 quarters since.
Denver Investment Advisors's Core Laboratories position peaked at $10.3M in Q3 2013.
355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.